Business Process Management

WHITE PAPERS AND CASE STUDIES

• Material Selection For Medical Device Manufacturability

  Choosing the right material in the earliest stages of research & development can make all the difference in beating your competitors to market and avoid increased project costs, development delays and manufacturing setbacks.

• Enhancing Preclinical Cell Therapy Development

  Automation in cell therapy development boosts reproducibility, reduces error, and enhances yield. Learn how it’s reshaping preclinical workflows and accelerating clinical trial readiness.

• How Waterloo Harnessed Qatium's Digital Platform

  Read about the City of Waterloo, that needed an intuitive, low-cost tool to empower operators without requiring specialized technical expertise.

• Hillshire Brands Uses Manufacturing Intelligence

  Explore solutions utilized by the Jimmy Dean brand, part of the Hillshire Brands portfolio, to address weight variance in one-pound sausage rolls that was driving up product giveaway and lost revenue.

• Preparing The Next Generation Of Clinical Research Professionals

  Explore the live EDC platform that enabled Durham Tech to create a model for future-forward, hands-on education in clinical research.

• Catalent's Journey Of Continuous Improvement For CSV Excellence

  Learn how organizations must continuously reassess validation processes and digital tools to ensure compliance, enhance efficiency, and support global scalability amidst evolving regulatory expectations.

• 7 Critical Factors For Predictable Quality In Medical Device Manufacturing

  Quality medical device production requires diverse engineering expertise, electronic integration, and a proven track record across seven key elements.

• Why Early Market Access Planning Is Crucial In CGT Commercial Strategy

  Bringing cell and gene therapies (CGTs) to market and ensuring patient access is a complex process. Discover how developing a market access strategy and partnering with experts can help.

• Improve Your Molecular Cloning Process With Synthetic Biology Automation

  Explore the promising field of synthetic biology, the hurdles manufacturers face with it's workflow, and how automation can help accelerating throughput and walkaway time.

• NuGenesis 9.3 – What's New

  Explore the latest features of a user-centric lab management system that comprises data, workflow, and sample management capabilities to support the entire product lifecycle.

• The Promise Of PCM: Getting To Maturity

  PCM offers a number of advantages, including streamlined development and increased flexibility. Review the key drivers for PCM as well as the hurdles that stand in the way of industry-wide adoption.

• 3 Ways To Address Sterility Assurance Requirements Of The EU GMP Annex 1

  Learn about the three key proactive steps companies need to take to meet the sterility assurance requirements of the EU GMP Annex 1 for the manufacture of sterile medicinal products.